The delta opioid receptor, a member of the G-protein-coupled receptor super
family, was used as a model system to characterize opioid receptor downregu
lation, Metabolic labeling followed by immunoprecipitation resulted in the
isolation of the epitope-tagged mouse delta opioid receptor as a similar to
60-kDa protein. Prolonged agonist treatment with 100 nM d-Ala(2), d-leu(5)
-enkephalin (DADLE) caused significant (similar to 60%) reduction in the le
vel of receptor. The delta opioid receptor contains a number of phosphoryla
table residues in the C tail. Point mutations of the majority of Ser/Thr se
quences did not affect the level of downregulation, whereas mutation of Thr
353 to Ala did. In order to test if phosphorylation at this site is involve
d in receptor downregulation, we generated a Thr353Glu mutant that would mi
mic the phosphorylated Thr at this site. This mutant exhibited a significan
tly higher extent of downregulation than the Thr353Ala mutant. In order to
critically evaluate the requirement of Thr353 in receptor downregulation, w
e examined the downregulation of wildtype rat delta receptor (which does no
t contain Ala353) and an Ala353Thr point-mutant rat delta receptor. The wil
dtype receptor exhibited poor agonist-mediated downregulation, whereas Ala3
53Thr mutant exhibited increased downregulation. These results and results
from additional studies with rat/mouse chimeric receptors support a role fo
r phosphorylation of sites within the C tail in efficient downregulation of
delta opioid receptors,.